Injectable Wegovy produced an average weight loss of around 15 percent in major trials, while tirzepatide, sold as Zepbound for obesity, has produced around 20 percent or more weight loss depending on dose and population
Berberine research includes multiple randomized controlled trials examining its effects on glucose metabolism, lipid profiles, and weight management in various populations
Review the detailed semaglutide versus tirzepatide comparison to understand the practical differences
"We know from the Diabetes Prevention Program that yes, if we improve weight without medication, if they're able to improve it by 5% to 7%, even that smaller amount of weight does improve people's different chronic conditions," Alexander explained
Healthcare provider recommending treatment intensification beyond basal insulin
As soon as liver fat falls, metabolic health follows